These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 8457655

  • 1. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ, Eisenberg PR, Abendschein DR.
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M, D'Aprile AM, Italia A, Gresele P, Morser J, Semeraro N.
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [Abstract] [Full Text] [Related]

  • 4. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC, Dieter JP, Strebel LC, Taylor TM, Muscolino G, Feinberg H, Le Breton GC.
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [Abstract] [Full Text] [Related]

  • 5. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).
    Trusen B, Ries M, Zenker M, Rauh M, Beinder E, Keuper H, Harms D.
    Semin Thromb Hemost; 1998 Dec; 24(6):599-604. PubMed ID: 10066156
    [Abstract] [Full Text] [Related]

  • 6. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Thromb Haemost; 1991 Nov 01; 66(5):592-7. PubMed ID: 1839474
    [Abstract] [Full Text] [Related]

  • 7. Standard and low molecular weight heparin have no effect on tissue plasminogen activator induced plasma clot lysis or fibrinogenolysis.
    Weitz JI, Kuint J, Leslie B, Hirsh J.
    Thromb Haemost; 1991 May 06; 65(5):541-4. PubMed ID: 1651568
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G, Blinc A, Strukelj M, Mikac U, Sersa I.
    Thromb Haemost; 2004 Mar 06; 91(3):487-96. PubMed ID: 14983224
    [Abstract] [Full Text] [Related]

  • 16. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI, Leslie B, Ginsberg J.
    J Clin Invest; 1991 Mar 06; 87(3):1082-90. PubMed ID: 1900308
    [Abstract] [Full Text] [Related]

  • 17. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential.
    Onundarson PT, Francis CW, Marder VJ.
    J Lab Clin Med; 1992 Jul 06; 120(1):120-8. PubMed ID: 1613318
    [Abstract] [Full Text] [Related]

  • 18. Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.
    Urano T, Nagai N, Matsuura M, Ihara H, Takada Y, Takada A.
    Thromb Haemost; 1998 Jul 06; 80(1):161-6. PubMed ID: 9684803
    [Abstract] [Full Text] [Related]

  • 19. Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro.
    Lourenço DM, Dosne AM, Kher A, Samama M.
    Thromb Haemost; 1989 Nov 24; 62(3):923-6. PubMed ID: 2556812
    [Abstract] [Full Text] [Related]

  • 20. Influence of factor XIIIa activity on human whole blood clot lysis in vitro.
    Jansen JW, Haverkate F, Koopman J, Nieuwenhuis HK, Kluft C, Boschman TA.
    Thromb Haemost; 1987 Apr 07; 57(2):171-5. PubMed ID: 2440124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.